• OUR COMPANY
  • R&D
  • FOUNDER
  • INVESTORS
  • The InnoBM(InnoBM Pharmaceuticals Co., Ltd.) was founded in May, 2019. The founder of InnoBM is Dr. Zhuang Liu, who is a world-renown scientist in the field of biomaterials. Based on the original research from Dr. Zhuang Liu’s research team, InnoBM is currently developing novel therapeutics to boost the efficacy of tumor immunotherapy. Our aimed products could be used alone, or synergize with existing therapeutics, especially immunotherapeutics currently used in clinic, to achieve the optimal therapeutic outcome.  

    The company is currently located in BioBay, Suzhou Industrial Park of Suzhou. We are a young and energetic team with shared values. Our mission is to bring in revolutionary medicines and solutions to address unmet clinical demands, and find new hopes for cancer patients.

    Company History
    • 2019
    • 2020
    • 2021
    • 2022
    2019

    May - InnoBM was founded.

    June - InnoBM received the angel investment. 

    2020

    September - InnoBM moved into the current space in BioBay of Suzhou.

    October – The CMC R&D platform was established.

    December – InnoBM received the Pre-A round investment.


    2021

    September - Dr. Zhuang Liu received the Xplorer Prize.

    November – InnoBM’s related pipeline JN001 was licensed-out to a partner company.

    December – Pre-IND inquire for BM201 was submitted.


    2022

    2022

    Unit 104, Building A4, No.218 Xinghu Street,

    Suzhou Industrial Park, Jiangsu Province, CHINA

    Tel:0512-69386599

    Mail:info@innobm.cn

    Copyright © 2023 InnoBM Pharmaceuticals Co., Ltd.  苏ICP备2023002766号-1  Technical Support: YUANDI